Roche acquires Flatiron Health for $1.9b


Roche Holding AG, a $54.1b research-focused, biotechnology company is acquiring Flatiron Health, a developer of an OncologyCloud platform which includes medical record for oncology, advanced analytics, patient portal and integrated billing for $1.9b. Flatiron’s cancer-centric electronic health records platform is connected to about 250 community oncology practices; it has a partnership with the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH), to improve clinical trials by gathering data at the point of care.Its platform captures and normalizes both structured and unstructured oncology data from diverse source systems. Roche was already a major investor and had a 12.6% stake. The acqusition adds new technology and data analytics infrastructure needed by Roche. Deal value -- $1.9b


Keywords: Healthcare Investment Banking, Healthcare M&A, Healthcare mergers